ABBV
ABBV, or AbbVie Inc., is a global biopharmaceutical company that focuses on developing and marketing advanced therapies for complex diseases.
Asset Summary
Loading summary…
Asset Performance Metrics and Risk Characteristics:
Metrics below use daily returns for Jan 1, 2026 – Aug 17, 2026 (YTD).
Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.
1 Month Trailing Return
-1.98%
Represents the percentage change in asset value over the past month.
3 Month Trailing Return
19.13%
Indicates the percentage change in asset value over the last three months.
Period Max Drawdown
16.43%
The highest percentage drop from the peak value to the lowest point during the observed period.
Standard Deviation
27.78%
Shows how much the asset’s daily returns deviate from the average, annualized for the entire period.
Sharpe Ratio
0.63
Measures the average return earned in excess of the risk-free rate per unit of volatility, annualized.
Calmar Ratio
1.07
The ratio of the annualized return to the maximum drawdown, reflecting the return per unit of risk.
Asset Technical Analysis
Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. Using indicators such as moving averages, pivot levels, momentum studies, and candlestick pattern scans can clarify trend strength and volatility. The tabs below summarize moving averages, pivots, technical indicators, candlestick patterns, and recent prices for this symbol.
Analysis
Moving Averages
Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:
| Type/Period | |
|---|---|
| SMA | |
| EMA | |
| WMA | |
| WEMA |
- SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
- EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
- WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
- WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.
Empower Your ABBV Trading Now
Maximize your trading efficiency with OHLCX.com. Our advanced trading system provides detailed insights and actionable strategies for ABBV. Don’t wait—Enhance your market performance today and see how our platform can help you achieve your trading goals!
Enhance Your Trading NowFrequently Asked Questions
-
As of the latest update, ABBV has a dividend yield of approximately 4.4%, reflecting its commitment to returning value to shareholders.
-
ABBV’s performance can be compared to other biopharmaceutical companies, focusing on product pipeline success, market share, and revenue growth.
-
Investors can purchase shares of ABBV through a brokerage account, as it is publicly traded on the New York Stock Exchange (NYSE) under the ticker symbol "ABBV."
-
Similar companies include Pfizer, Merck, and Johnson & Johnson, which also focus on pharmaceuticals and biopharmaceuticals.
-
Dividends paid by ABBV can be reinvested to purchase additional shares or received in cash, depending on the investor’s preference.
-
ABBV is managed through various therapeutic areas, including immunology, oncology, neuroscience, and virology, with a strong emphasis on research and development.
-
Yes, risks include competition in the biopharmaceutical space, regulatory challenges, and the potential for patent expirations on key products.
-
ABBV typically distributes dividends on a quarterly basis, providing a steady income stream for investors.
-
ABBV offers a range of pharmaceuticals, including treatments for immunological conditions, oncology therapies, and neuroscience-related medications.
-
ABBV does not undergo traditional rebalancing like an ETF, but it regularly assesses its product pipeline and strategic initiatives to optimize performance.
Top Market Assets
Discover our curated selection of top-performing exchange-traded funds (ETFs) that represent a diverse range of investment opportunities.
SPY is an exchange-traded fund (ETF) that aims to replicate the performance of the S&P 500 Index. The S&P 500 Index includes 500 of the largest publicly traded companies in the United States, representing a broad cross-section of the U.S. economy.
QQQ is an exchange-traded fund (ETF) that tracks the performance of the Nasdaq-100 Index. This index includes 100 of the largest non-financial companies listed on the Nasdaq Stock Market, primarily focusing on technology and innovation sectors.
DIA is an exchange-traded fund (ETF) that aims to track the performance of the Dow Jones Industrial Average (DJIA). The DJIA is a stock market index consisting of 30 large, publicly traded companies in the United States, representing a broad range of industries.
IWM is an exchange-traded fund (ETF) that seeks to track the performance of the Russell 2000 Index. The Russell 2000 Index measures the performance of the 2,000 smallest stocks in the Russell 3000 Index, representing a broad segment of small-cap U.S. companies.
Asset Related News
Advance Your ABBV Trading Now
Achieve superior trading results with OHLCX execution platform. Our platform provides expert analysis and actionable insights for ABBV, utilizing the latest technology to refine your investment approach. Start optimizing your trades today now and see the impact on your trading success!
Disclaimers
The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.
With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.
Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.
Securities products are: Not FDIC insured · Not bank guaranteed · May lose value
Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.